A
6.00
0.18 (3.09%)
| Penutupan Terdahulu | 5.82 |
| Buka | 5.99 |
| Jumlah Dagangan | 258,820 |
| Purata Dagangan (3B) | 252,064 |
| Modal Pasaran | 82,783,200 |
| Harga / Buku (P/B) | 9.20 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 Nov 2024 |
| EPS Cair (TTM) | -4.22 |
| Nisbah Semasa (MRQ) | 2.66 |
| Aliran Tunai Operasi (OCF TTM) | -22.97 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -11.57 M |
| Pulangan Atas Aset (ROA TTM) | -154.58% |
| Pulangan Atas Ekuiti (ROE TTM) | -596.70% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Annovis Bio, Inc. | Menurun | Menurun |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.00 |
|
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 20.40% |
| % Dimiliki oleh Institusi | 8.83% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Quest Partners Llc | 30 Sep 2024 | 46,002 |
| Wescott Financial Advisory Group, Llc | 30 Sep 2024 | 41,607 |
| Sterling Investment Advisors, Ltd. | 30 Sep 2024 | 34,474 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 30.00 (HC Wainwright & Co., 400.00%) | Beli |
| Median | 23.00 (283.33%) | |
| Rendah | 21.00 (D. Boral Capital, 250.00%) | Beli |
| 21.00 (EF Hutton, 250.00%) | Beli | |
| Purata | 24.25 (304.17%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 8.29 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| D. Boral Capital | 11 Nov 2024 | 21.00 (250.00%) | Beli | 7.65 |
| HC Wainwright & Co. | 11 Nov 2024 | 30.00 (400.00%) | Beli | 7.65 |
| 16 Oct 2024 | 30.00 (400.00%) | Beli | 9.14 | |
| Maxim Group | 25 Oct 2024 | 25.00 (316.67%) | Beli | 9.87 |
| EF Hutton | 15 Oct 2024 | 21.00 (250.00%) | Beli | 7.98 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |